Dan Atar

Adjunct Professor - Division of Medicine
Image of Dan Atar
Norwegian version of this page
Phone +47 22119100
Mobile phone +47 98074757
Username
Visiting address Kirkeveien 166 Bygning 3 0450 Oslo
Postal address OUS HF Ullevål sykehus Postboks 4956 Nydalen 0424 Oslo

Head of Research - Division of Medicine

Academic interests

  • Granting from Eurostars in 2020 for 'WATCH IT'. Grant administrated by The Research Council of Norway.
  • Granting from Eurostars in 2020 for 'PILLOXA'. Grant administrated by The Research Council of Norway.
  • Climate and Cardiovascular Health (EU-Horizon grant “EXHAUSTION” – partner)

  • BETAMI trial (BETAMI: BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function)
  • Prevention of reperfusion injury in myocardial infarction
  • Troponin - both molecular and clinical aspects
  • "FIRE"-trial: Chair of study in patients with myocardial infarction
  • EU-FP7, MITOCARE: Head of clinical trial consortium to study patients with myocardial infarction
  • Atrial fibrillation - pharmacotherapy

Courses taught

Teaches the entire spectrum of Cardiology at all levels (pregraduate / postgraduate)

Higher education and employment history

  • Board-certified specialist in Cardiology and Internal Medicine from Denmark and Switzerland.
  • Visiting Associate Professor of Cardiology at The Johns Hopkins Unversity, Baltimore, MD, USA

Prizes

  • One of the 25 researchers working at Norwegian institutions who are on the list of the world's most quoted researchers. Khrono 2019
  • Ranked as one of the 12 most quoted researchers in Norway. November 2016.
  • Doctor honoris causa, Universitet Bucharest. June 2016
  • Researcher of the month, Helse SørØst, March 2015
  • Norsk Cardiologisk Selskap’s vitenskapelige pris «Ole Storsteins Pris» 2014
  • Best teacher/lecturer 2014 (5th and 6th semester, Medicin, UiO)
  • Research prize winner of the ISHR (Int. Soc. Heart Research), 1994
  • Winner of the Swiss Heart Foundation Research Prize in 1995
  • Research Prize of the Danish Society of Internal Medicine, 1994

Positions held

  • Editor-in-Chief Cardiology, since 1.1.2019

  • Elected Treasurer/Secretary of the ESC, 2018-2020

  • Associate Editor, European Heart Journal – Cardiovascular Pharmacotherapy
  • Vice-President of the ESC Board 2014-1016
  • Councillor of the ESC Board, 2012-2014
  • Treasurer and member of the Board: NCS (Norwegian Society of Cardiology)
  • Previous Chairman of Working Group Pharmacotherapy under the ESC (Euorp.Soc.Cardiology)
  • Member of the CPC (Congress Program Committee under ESC
  • Member of the Guideline Writing Committee for "ESC 2012 STEMI Guideline" and for the "ESC/AHA/ACC/WHF Global Definition of MI" Guideline
  • Previous Guidelines committee memberships: ESC 2010 Atrieflimmer, ESC 2008 Heart Failure
  • Member of the Steering Committee of the CHFR (Center for Heart Failure Research, Oslo)
  • Assoc. Editor: "Cardiology"

Collaboration

  • University of Texas, Houston. (Prof. Jochai Birnbaum)
  • Sydney University (Prof. Tony Keech)
  • The Johns Hopkins University, Baltimore, MD, USA (Assoc.Prof. V. L. Serbruany)
  • Zurich Universitetshospital (Prof. T. F. Lüscher)
Tags: Myocardial Infarction, Prevention of Reperfusion Injury, Troponin, Cardiovascular Pharmacotherapy, India, Nordic
Published Apr. 13, 2011 2:53 PM - Last modified Aug. 24, 2020 1:24 PM